Lung Cancer Treatment

If you have been diagnosed with lung cancer and cannot access the treatment you need at home, here is what your options actually look like in India.

A lung cancer diagnosis changes everything overnight. For patients across much of Africa, South Asia, and the Middle East, that diagnosis quickly runs into a harder wall: no thoracic surgical unit nearby, no immunotherapy programme, no PET-CT for accurate staging, and in many cases no access to the targeted therapies that now define modern lung cancer care. Travelling for treatment is not an extraordinary step. It is what tens of thousands of patients from these regions do every year, for exactly this reason.

Lung cancer treatment in India covers the full range of approaches for Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and carcinoid tumours. Depending on your stage and biopsy results, your oncology team will recommend surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination. India's top hospitals run multidisciplinary tumour boards, where oncologists, radiologists, surgeons, and pathologists review every case together before recommending a plan. This model is standard at Apollo, Medanta, Max, and BLK-Max, and it is not widely available across most of Africa or South Asia.

As of 2026, lung cancer surgery (lobectomy) in India costs $7,000 to $15,000 USD at private hospitals. Radiation therapy ranges from $3,800 to $5,800 USD, and chemotherapy runs $300 to $600 USD per cycle depending on the drug. These figures are significantly lower than comparable private treatment in regional medical hubs, not because standards are lower, but because hospital operating costs and procedure volumes differ structurally. For early-stage lung cancer treated with surgery, 5-year survival rates at India's leading centres reach 50 to 75%, with Stage IA patients achieving survival rates of up to 75%.

Apollo Hospitals, Medanta, Fortis, Max Healthcare, and BLK-Max all hold JCI (Joint Commission International) accreditation, the same standard applied to leading hospitals in the US and Europe. Apollo has dedicated international patient centres in several African cities and has treated thousands of lung cancer patients from Kenya, Nigeria, and East Africa. Manipal Hospitals' oncology team was among the first in India to apply next-generation sequencing (NGS) to identify EGFR mutations in lung cancer patients arriving from Africa, converting patients who had received ineffective chemotherapy to targeted oral therapies with significantly better outcomes.

One specific advantage worth understanding: robotic-assisted lobectomy, a minimally invasive approach that reduces bleeding, hospital stay, and recovery time compared with open surgery, is available at Apollo, Medanta, and Max. It is not available at most hospitals across Africa and South Asia. If you are a surgical candidate, your tumour board will consider this option as part of your plan.

MediVenza handles your medical visa invitation letter, confirms your hospital booking and oncology consultation before you travel, arranges airport pickup on arrival, provides an interpreter throughout your stay, and books family accommodation near the hospital. Your coordinator remains available throughout your treatment and prepares your discharge documentation and follow-up schedule before you fly home.

Want a Clear Picture Before You Decide?

Send your medical reports to [email protected] or WhatsApp +919899655596. Our team will review your case and give you a clear picture of what to expect, costs, timeline, and next steps, within 24 hours. There is no obligation.

How Lung Cancer Treatment Works in India

Your assessment begins before you travel. Send your biopsy report, CT scan, and PET-CT (if available) to MediVenza for remote pre-assessment. Your oncology team will review the stage and type of your lung cancer and confirm the recommended treatment approach before you book your flight.

On arrival, your first appointment is a full diagnostic review. If staging imaging is incomplete, your hospital will arrange CT, PET-CT, or bronchoscopy as needed. For surgical candidates (typically Stage I to III), lobectomy takes 3 to 5 hours under general anaesthesia. Minimally invasive and robotic-assisted approaches are available at Apollo, Medanta, and Max. Hospital stay after surgery is 7 to 8 days, followed by 3 to 4 weeks in India for monitoring before you are cleared to fly home.

Apollo, Medanta, Fortis, Max, and BLK-Max all have dedicated thoracic oncology units for international patients. An interpreter is present throughout your consultations and treatment. Your MediVenza coordinator is on call during your entire stay and can be reached 24/7 if you or your family need support at any point.

Recovery After Lung Cancer Treatment: What to Expect

After surgery, you remain in hospital for 7 to 8 days. You then stay in India for approximately 3 to 4 additional weeks for wound monitoring and a follow-up oncology consultation before your discharge clearance. Flying is typically permitted 4 to 6 weeks after surgery, subject to your oncologist's clearance.

Before you fly home, your hospital provides a full discharge summary, surgical report, pathology findings, and recommended follow-up schedule. Share these documents with your local doctor on return. For the first three months at home, expect oncology follow-up every 4 to 6 weeks including blood tests. CT scans are recommended every 6 to 12 months for the first two years to monitor for recurrence.

If oncology access is limited in your home country, MediVenza arranges telemedicine follow-up consultations with your treating team in India at no additional cost. During recovery, avoid heavy lifting for 6 to 8 weeks, stop smoking completely, and return to normal activity gradually as guided by your oncologist.